Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONgenital CMV: Efficacy of antiviral treatment in a randomized controlled trial
2011-005378-44Phase 3Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valganciclovir in congenital cytomegalovirus infection (cCMV), sponsored by Leiden University Medical Center. Started Apr 2012; status: terminated.
02
Drugs
valganciclovir
03
Conditions
congenital cytomegalovirus infection (cCMV)
Beyond the preview
Go deeper on 2011-005378-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005378-44.